Northside Hospital, Inc. - GCS/Northside — Atlanta, Georgia

Northside Hospital, Inc. - GCS/Northside is a clinical research site located in Atlanta, Georgia, United States 30342.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Northside Hospital, Inc. - GCS/Northside has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Breast Neoplasms, Locally Advanced or Metastatic Solid Tumors.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northside Hospital, Inc. - GCS/Northside?

Northside Hospital, Inc. - GCS/Northside has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northside Hospital, Inc. - GCS/Northside conducted?

Northside Hospital, Inc. - GCS/Northside has 3 clinical trials on record, with 1 currently active. Their work covers HER2-positive Breast Cancer, Breast Neoplasms, Locally Advanced or Metastatic Solid Tumors.

Is Northside Hospital, Inc. - GCS/Northside accredited by Crixeo Health?

Northside Hospital, Inc. - GCS/Northside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northside Hospital, Inc. - GCS/Northside?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.